We are more prosperous, but mentally sicker than ever. Does prosperity bring bad luck? In this podcast Damiaan Denys and Ilse Graat discuss the paradox between greater economic wealth and the increase of mental complaints. Additionally, Damiaan talks about the choices he made as an early career researcher, his professional journey and his reasons to combine philosophy, psychiatry, clinical work and scientific research. One of his research topics focusses on confidence, in this podcast he explains that confidence abnormalities are associated with different psychiatric disorders. Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

The COVID pandemic created a beneficial momentum in mental health research. In this podcast, Celso Arango and Aiste Lengvenyte discuss the challenges in youth mental health including awareness, prevention and access to treatment. They also talk about the latest discoveries on the causes of neurodevelopmental conditions and the need for a more dimensional approach in mental health. Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

The use of psychedelics in the treatment of psychiatric disorders has been receiving widespread attention from the nonprofessional and scientific community for the last few years. The practice of taking a small, non-psychedelic dose of LSD or psilocybin to improve particular behaviour, emotions, or a psychiatric condition is claimed to be effective by its users. In this podcast Ilse Graat, the Netherlands, interviews Kim Kuypers, the Netherlands, on her path towards psychedelics, discussing where this young research field stands and where it is heading, including new research on microdosing yet to be explored.Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

Would you like to know ‘why we just don’t do the things we know are good for us?’ listen to part two of the podcast series with Silke Matura and Veerle van Gils. Learn more on the effects of lifestyle on cognition and get familiar with the various techniques used to measure different types of cognition. Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

In part one of the two-part podcast series, recorded during the ECNP Congress in Vienna, PhD student Veerle van Gils and senior clinical scientist and psychologist Dr Silke Matura discuss the role of dysfunctional insulin signalling as modulator of mental and non-mental chronic diseases. They are both part of the PRIME (Prevention and Remediation of Insulin Multimorbidity in Europe) project trying to identify and specify the molecular mechanisms underlying insulin comorbidities. Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

In this podcast Andreas Reif, past-chair of the Scientific Programme Committee, is in conversation with Early Career Advisory Panel chair Nils Opel. Andreas Reif, who studies molecular underpinnings of neuropsychiatric disorders, talks about his life in science and how science has speeded up since he started his career. In addition, he shares some advice to ensure a successful career start, elaborates on his participation in research networks and the impact of the COVID19 pandemic on research and mental health Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

ECNP president Gitte Knudsen talks about neurobiology, her personal career history and future plans. Additionally, she gives advice to Early Career researchers on creating a successful career without neglecting personal life.Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

In this episode, Catherine Harmer, the director of the Psychopharmacology and Emotional Research Lab at the University of Oxford, talks about her research path and the major findings on the mechanisms behind emotional processing and depression. She also discusses novel findings on the cognitive mechanisms of the response to drugs used in the treatment of depression and anxiety.Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.

In this very first ECNP podcast, professor David Nutt, Imperial College of London, a leading expert in neuropsychopharmacology, shares his thoughts about the major findings in brain science and the future of psychiatry. He also talks about his curious path as a psychiatrist-turned-researcher and a fierce advocate for evidence-based treatments and policies. Views and opinions expressed in this podcast are those of the interviewee and do not necessarily reflect the official position of ECNP. The content of this podcast should not be used in any way as the basis for treatment decisions.